Lipids as a target for drugs modulating multidrug resistance of cancer cells

被引:164
作者
Hendrich, AB [1 ]
Michalak, K [1 ]
机构
[1] Wroclaw Med Univ, Dept Biophys, PL-50368 Wroclaw, Poland
关键词
D O I
10.2174/1389450033347172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this review we focus on the role of the membrane lipids in multidrug resistance and its modulation. Results of the research performed in recent years indicate the importance of lipid phase playing active role in many membrane processes. Along with the alterations of lipid membrane composition of cancer cells (with respect to the normal ones) the resulting changes of the biophysical membrane properties are discussed. Next we describe the general features of multidrug resistance phenomenon paying a special attention to the role of lipids and alterations of lipid membrane composition in MDR cells. Taking into account the phase separation properties of sphingolipids the importance of membrane heterogeneity (presence of caveole and lipid rafts) is emphasised. On the basis of vacuum cleaner hypothesis of drug transport proteins action we discuss the importance of lipid bilayer as medium in which diffusion of drugs takes place. Considering the membrane fluidity and its influence on the integral proteins activity, we underline the role of balance between the passive cellular influx and active efflux of the drug molecules. Finally the effects exerted on membranes by different kinds of multidrug resistance modulators (chemosensitizers) are described. In this part we discuss the influence of verapamil, phenothiazine derivatives, tamoxifen and chosen flavonoids on the biophysical properties of membrane lipids. Some further consequences of the alteration of membrane state are also considered.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 94 条
[51]   Cell membrane fluidity and adriamycin retention in a tumor progression model of AKR lymphoma [J].
Leibovici, J ;
Klein, O ;
Wollman, Y ;
Donin, N ;
Mahlin, T ;
Shinitzky, M .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1996, 1281 (02) :182-188
[52]   Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids [J].
Leslie, EM ;
Mao, QC ;
Oleschuk, CJ ;
Deeley, RG ;
Cole, SPC .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1171-1180
[53]   Baculovirus-based expression of mammalian caveolin in Sf21 insect cells A model system for the biochemical and morphological study of caveolae biogenesis [J].
Li, SW ;
Song, KS ;
Koh, SS ;
Kikuchi, A ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28647-28654
[54]  
LIEBES LF, 1981, CANCER RES, V41, P4050
[55]   Determining the structure and mechanism of the human multidrug resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques [J].
Loo, TW ;
Clarke, DM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :315-325
[56]   The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids [J].
Margolles, A ;
Putman, M ;
van Veen, HW ;
Konings, WN .
BIOCHEMISTRY, 1999, 38 (49) :16298-16306
[57]   Role of sphingolipids in the biogenesis of membrane domains [J].
Masserini, M ;
Ravasi, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1532 (03) :149-161
[58]   PLASMA-MEMBRANE LIPID-COMPOSITION OF VINBLASTINE SENSITIVE AND RESISTANT HUMAN-LEUKEMIC LYMPHOBLASTS [J].
MAY, GL ;
WRIGHT, LC ;
DYNE, M ;
MACKINNON, WB ;
FOX, RM ;
MOUNTFORD, CE .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :728-733
[59]   Interplay of C1 and C2 domains of protein kinase C-α in its membrane binding and activation [J].
Medkova, M ;
Cho, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) :19852-19861
[60]   ESOPHAGEAL CANCER PHOSPHOLIPID CHARACTERIZATION BY P-31 NMR [J].
MERCHANT, TE ;
DEGRAAF, PW ;
MINSKY, BD ;
OBERTOP, H ;
GLONEK, T .
NMR IN BIOMEDICINE, 1993, 6 (03) :187-193